{"id":"W4410455898","doi":"10.1016/j.esmoop.2025.104875","title":"303MO Zanidatamab (Zani) + chemotherapy (Chemo) for patients (Pts) with HER2-expressing metastatic breast cancer (mBC): Final results of a phase I trial","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto; Ottawa Hospital; University Health Network","funders":"","keywords":"Metastatic breast cancer; Medicine; Chemotherapy; Oncology; Internal medicine; Breast cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006607528,0.000789134,0.001354888,0.0002352733,0.0002746416,0.0007649846,0.0004068575,0.0007110619,0.005649189],"category_scores_gemma":[0.0005394745,0.0003328596,0.001231019,0.0003369263,0.0004049053,0.0004628755,0.0002763062,0.002093593,0.001146464],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005972152,"about_ca_system_score_gemma":0.0007869247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001381492,"about_ca_topic_score_gemma":0.006552115,"domain_scores_codex":[0.999848,0.00006192248,0.000007773433,0.00002483085,0.00001534261,0.00004209105],"domain_scores_gemma":[0.9998001,0.00003524104,0.00004435629,0.00001555449,0.00001701797,0.00008771756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.649155,0.01624863,0.00723406,0.003050166,0.003558689,0.0001774419,0.0002293837,0.002538508,0.0239378,0.0008676067,0.01236833,0.2806344],"study_design_scores_gemma":[0.7791393,0.1717977,0.02480313,0.00029095,0.002611213,0.0003610387,0.0001201754,0.001350947,0.002537183,0.0005906018,0.01635229,0.00004537195],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9681832,0.01797766,0.0005420823,0.001648596,0.0004935677,0.001780886,0.002248075,0.0001449766,0.00698091],"genre_scores_gemma":[0.9575675,0.02040348,0.002381265,0.002624304,0.0003183291,0.001377246,0.004941996,0.00006060933,0.0103253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005649189,"threshold_uncertainty_score":0.01889837,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0616610548272806,"score_gpt":0.4285064569520884,"score_spread":0.3668454021248078,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}